|
|
||||||||
Papers In Press, published online ahead of print February 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medicine Dept., University of California, San Francisco, San Francisco, CA 94121
Corresponding Author: skerick{at}itsa.ucsf.edu
Cholesterol 7a-hydroxylase, a rate-limiting enzyme for bile acid synthesis, has been implicated in genetic susceptibility to atherosclerosis. The gene, CYP7A1, encoding a protein with this activity, is expressed normally only in hepatocytes and is highly regulated. Our cyp7A1 gene knockout mouse colony, as young adults on a chow diet, is hypercholesterolemic. These mice were characterized extensively to understand how cyp7A1 affects lipid and bile acid homeostasis in different tissue compartments and whether gender plays a modifying role. Both male and female cyp7A1 deficient mice had decreased hepatic low density lipoprotein receptors, unchanged hepatic cholesterol synthesis, increased intestinal cholesterol synthesis and bile acid transporters, and decreased fecal bile acids but increased fecal sterols. In females, cyp7A1 deficiency also caused changes in hepatic fatty acid metabolism, decreased hepatic canalicular bile acid transporter, Bsep, and altered gall bladder bile composition to a lithogenic profile. Taken together, the data suggest that cyp7A1 deficiency results in a proatherogenic phenotype in both genders and leads to a prolithogenic phenotype in females.
Revised on February 3, 2003
Accepted on February 4, 2003
Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female CYP7A1 deficient mice
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. M. Post, M. Groenendijk, C. C. van der Hoogt, C. Fievet, G. Luc, M. Hoekstra, H. M.G. Princen, B. Staels, and P. C.N. Rensen Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Increases Hepatic ABCA1 mRNA Expression and HDL-Cholesterol Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2724 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dubrac, S. R. Lear, M. Ananthanarayanan, N. Balasubramaniyan, J. Bollineni, S. Shefer, H. Hyogo, D. E. Cohen, P. J. Blanche, R. M. Krauss, et al. Role of CYP27A in cholesterol and bile acid metabolism J. Lipid Res., January 1, 2005; 46(1): 76 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dai, G. A. Abou-Rjaily, Q. Y. Al-Share', Y. Yang, M. A. Fernstrom, A. M. DeAngelis, A. D. Lee, L. Sweetman, A. Amato, M. Pasquali, et al. Interaction between Altered Insulin and Lipid Metabolism in CEACAM1-inactive Transgenic Mice J. Biol. Chem., October 22, 2004; 279(43): 45155 - 45161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Post, M. Groenendijk, K. Solaas, P. C. N. Rensen, and H. M. G. Princen Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Impairs Very-Low-Density Lipoprotein Production Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |